# Study of FOLFIRINOX Electrochemotherapy in the Treatment of Pancreatic Adenocarcinoma

> **NCT02592395** · PHASE1 · WITHDRAWN · sponsor: **The University of Texas Health Science Center, Houston**

## Conditions studied

- Pancreatic Adenocarcinoma

## Interventions

- **DRUG:** FOLFIRINOX
- **DEVICE:** Electroporation

## Key facts

- **NCT ID:** NCT02592395
- **Lead sponsor:** The University of Texas Health Science Center, Houston
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2015-10
- **Primary completion:** 2017-10
- **Final completion:** 2017-10
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** PI transferred to another institution and did not take this study with him.
- **Last updated:** 2018-10-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02592395

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02592395, "Study of FOLFIRINOX Electrochemotherapy in the Treatment of Pancreatic Adenocarcinoma". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02592395. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*